MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy - Concepedia

Concepedia

Publication | Open Access

MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy

DOI Full Paper Access

80

Citations

51

References

2012

Year

Consolación Melguizo, José Prados, Beatríz González, Raúl Ortíz, Ángel Concha, Pablo Álvarez, Roberto Madeddu, Gloria Perazzoli, Jaime Antonio Oliver, Rodrigo López,

Journal of Translational Medicine

References

	Year	Citations

Page 1